Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...

Discover the Cipla Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent stock.

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Here's what Goldman Sachs, Jefferies, JPMorgan, Citi, Morgan Stanley, CLSA, and Nomura make of stocks such as Bandhan Bank, ...

Citi Maintains Buy On Cipla | Goa Unit Warning Letter Under Scanner#cipla #ciplastocks #brokerageradar #citi #businessnews ...

Shares of several companies including TCS, Kotak Mahindra Bank, CIPLA, and Indus Towers, among others, will be in the news ...

Volatility is expected to continue in the market, with support at the current week's low. Below are some trading ideas for ...

The stock market opened flat Friday, with significant declines in Sensex and Nifty during initial trading. While several ...

Indian shares ended slightly lower on Friday as TCS' Q2 earnings failed to impress markets. A nearly 4 percent surge in oil prices ...